Low- & Middle-Income Countries in Africa and Middle East Begin Vaccine Rollout 16/02/2021 Madeleine Hoecklin & Kerry Cullinan As low- and middle-income countries begin receiving their first batches of vaccines and commence their vaccination campaigns, at least 40 countries across Africa are seeing a second wave and record case numbers are being reported in the southern African region, where the B.1.351 variant is spreading. Rwanda has become the first country in East Africa […] Continue reading -> WHO Special Envoy Expects Some Form Of A ‘Vaccine Passport’ In The Future – But Vaccine Shortages Are An Immediate Hurdle 16/02/2021 Madeleine Hoecklin A World Health Organization (WHO) Special Envoy for COVID-19 has suggested that ‘vaccine passports’ could prove to be an important part of future international travel regulations to stop the spread of COVID-19 and its variants. A growing number of countries around the world are in fact already racing ahead to create vaccine passport systems – […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Special Envoy Expects Some Form Of A ‘Vaccine Passport’ In The Future – But Vaccine Shortages Are An Immediate Hurdle 16/02/2021 Madeleine Hoecklin A World Health Organization (WHO) Special Envoy for COVID-19 has suggested that ‘vaccine passports’ could prove to be an important part of future international travel regulations to stop the spread of COVID-19 and its variants. A growing number of countries around the world are in fact already racing ahead to create vaccine passport systems – […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Even Though US Now Has Enough Vaccines For Entire Population, “Immense” Logistic Challenges Abound 14/02/2021 Madeleine Hoecklin The United States government has now secured enough COVID-19 vaccines to vaccinate every American adult after purchasing an additional 100 million doses each from Pfizer and Moderna, President Joe Biden said Thursday However, currently vaccines are in short supply across the country and logistic challenges abound. Biden used the option in the contracts negotiated last year […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Civil Society Organizations & Health Industries Unite In Call For Ratification of African Medicines Agency 08/02/2021 Madeleine Hoecklin Civil society organizations, pharmaceutical industries, and other stakeholders support the ratification of the AMA Treaty. On the two-year anniversary of the establishment of the African Medicines Agency (AMA) Treaty, over 40 patient and civil society organizations, health and pharmaceutical industries, and product development partnerships called upon African Union member states to ratify the Treaty. Rapidly […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Posts navigation Older postsNewer posts